GlassScriptPhysician profile
Craig E Brener
NPI 1669473609
$650.70
in general payments reported to CMS, 2019-2025
14 companies · $330 in 2025
The $330 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.07 · 2020: $60.20 · 2021: $73.30 · 2022: $21.35 · 2023: $55.53 · 2024: $70.40 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $130.15 | 2023-2025 | Tremfya, Simponi Aria, Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $87.28 | 2025 | Entyvio, Gattex |
| Abbvie INC. | $80.35 | 2019-2025 | |
| Acacia Pharma INC | $73.30 | 2021 | |
| Ardelyx, INC. | $57.87 | 2024-2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.37 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $31.19 | 2024 | |
| Qol Medical, LLC | $29.45 | 2025 | Sucraid |
| Rayner Intraocular Lenses Limited | $25.35 | 2025 | Omidria |
| Heron Therapeutics, INC. | $21.35 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.78 | 2024 | Dupixent |
| Laborie Medical Technologies Corp. | $19.19 | 2025 | |
| Biocon Biologics INC | $18.76 | 2025 | Yesintek |
| Braintree Laboratories, INC. | $15.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Brener listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.